SCR-LIP-000581 · Claim · machine-readable JSON →

Lipedema adipose tissue is reported to show histological and molecular features that differ from control tissue of similar body mass and from lymphedema.

General proposition consolidated from 5 earlier single-paper claims; each study's own result is shown as its finding.

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
moderate (GRADE)
Evidence
6 source(s)
Dates
2026-11-20 → 2026-11-20

Structured evidence, machine-compiled — not a verdict.

Evidence over time

20202025Adipose Tissue Hypertrophy, An Aberrant Biochemical Profile and Distinct Gene Expression in Lipedema — Felmerer et al. (2020) · consistentIncreased levels of VEGF-C and macrophage infiltration in lipedema patients without changes in lymphatic vascular morphology — Felmerer et al. (2020) · consistentCurrent Mechanistic Understandings of Lymphedema and Lipedema: Tales of Fluid, Fat, and Fibrosis — Duhon et al. (2022) · consistentLipedema: Insights into Morphology, Pathophysiology, and Challenges — Poojari et al. (2022) · consistentA Comparative Analysis to Dissect the Histological and Molecular Differences among Lipedema, Lipohypertrophy and Secondary Lymphedema — von Atzigen et al. (2023) · consistentVascular remodeling of adipose tissue in lipedema: endothelial dysfunction as an emerging culprit in a mysterious disease — Allerton (2025) · consistent

Evidence (6)

Context (PECO)

Populationwomen with lipedema vs. BMI-matched controls
Conditionlipedema
Exposurelipedema adipose tissue pathology
ComparatorBMI-matched non-lipedema controls
Outcomehistopathology, lipid metabolism, adipogenesis gene expression
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Change log